Som man betalar får man banta. En kvalitativ analys av hur traditionella nyhetsmedier gestaltar Ozempic
No Thumbnail Available
Date
2025-02-27
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
In the past year, Ozempic has been observed internationally, as well as in the Swedish press,
due to its rapid rise in popularity, its off-label use for weight loss, and the ethical and societal
debates surrounding availability and impact. The purpose of this study is to examine how
Ozempic is portrayed in the four largest Swedish daily newspapers: Svenska Dagbladet,
Dagens Nyheter, Expressen and Aftonbladet. The aim of the thesis is to identify the frames
within which the drug is described to acquire knowledge of how it influences public
perception of it. Every article published between the first of March until the first of
November has been included in the study, if it bottoms in the defined phonomenon. The
method used is a qualitative text analysis in consideration of Entman’s framing theory, which
is focusing on identifying dominant themes, problem definitions, proposed solutions, and the
actors attributed responsibility in the coverage of Ozempic in Swedish press. The results
revealed that Ozempic is discussed within various frames in Swedish media. One of the most
common frames in the articles is the access issues, regarding who has access to the
medication and who does not, which has shaped the overall discussion. Furthermore
differences between morning and evening press were identified. The morning press was more
factual and informative, with a focus on research, whereas the evening press tended to adopt
a more sensationalist approach, often emphasizing individual stories. The study also
confirmed earlier research regarding gender, socials and economics. Gender stood out since
the portrayal of Ozempic in articles often has a focus on women. This is evidenced by
imagery and narratives centered on women’s bodies, particularly in relation to weight loss.
Description
Keywords
Qualitative Text Analysis, Framing, Press, News, Ozempic, Weight loss, Svenska Dagbladet, Dagens Nyheter, Expressen, Aftonbladet